🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial is being conducted to determine tumor response and prel...
Status
Completed
Location
Site Reference ID/Investigator# 70538
Start Date
2005-03
Trial ID
NCT00401570
Treatments Being Tested
Radical cystectomy remains the gold standard treatment for invasive non met...
Status
Completed
Location
UHRouen
Start Date
2013-02
Trial ID
NCT01812369
Treatments Being Tested
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229
This was an open-label, nonrandomized, Phase 1/2 study designed to determin...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2017-05-02
Trial ID
NCT03085914
This study is comparing two combinations of chemotherapy treatments in pati...
Status
Unknown
Location
Aberdeen Royal Infirmary
Start Date
2017-11-28
Trial ID
NCT04151277
Treatments Being Tested
This phase II trial is studying how well giving gemcitabine, paclitaxel, an...
Status
Completed
Location
Ozark Health Ventures LLC dba Cancer Research for The Ozarks Springfield
Start Date
2007-04
Trial ID
NCT00478361
Treatments Being Tested
This randomized phase III trial studies how well gemcitabine hydrochloride ...
Status
Terminated
Location
Tennessee Valley Gynecologic Oncology
Start Date
2012-06-04
Trial ID
NCT01533207
The goal of this clinical research study is to find the highest tolerable d...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2011-08
Trial ID
NCT01421173
This study evaluates the effect of the serum level of Superoxide Dismutase ...
Status
Unknown
Location
First Hospital of Dalian Medical University
Start Date
2016-01
Trial ID
NCT02844114
Treatments Being Tested
This study is a multi-cohort, open-label, multi-center exploratory clinical...
Status
Not Yet Recruiting
Location
Shandong Cancer Hospital and Institute
Start Date
2024-10-10
Trial ID
NCT06649448